Downing Labs Recalls L-Tyrosine Injectable Due to Sterility Concerns
Downing Labs, LLC is recalling 29 vials of L-Tyrosine Injectable because the product lacks assurance of sterility. The affected product was distributed nationwide and in multiple international markets.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury/property-damage reports or hospitalization are rated Severe. While specific injury reports are not detailed in the provided text, the lack of sterility assurance in an injectable product represents a significant risk of harm consistent with the Severe classification for Class II drug recalls.
Plain-English summary
Downing Labs, LLC is recalling 29 vials of L-Tyrosine Injectable, 25mg/mL, 30mL vial, Rx only. The recall is being conducted because the product lacks assurance of sterility. The affected product is identified by the recall number D-0338-2016 and includes all lots.
The recalled product was distributed nationwide in the United States as well as in Australia, Brazil, the Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, the Philippines, Singapore, Thailand, Trinidad and Tobago, and Taiwan. The product is prescription-only.
Consumers and healthcare providers should stop using the recalled product and contact Downing Labs, LLC at 1-800-914-7435 for further instructions or to arrange for a return or replacement.
The recalled product
- Product
- L-Tyrosine Injectable, 25mg/mL, 30mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435
- Manufacturer
- Downing Labs, LLC
- Category
- Drug — Injectable
- Affected units
- 29
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 48 recalled by Downing Labs, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 48 products in this recall →Related recalls
Same manufacturer · Downing Labs, LLC
See all →- SevereDowning Labs Recalls Ascorbic Acid Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereDowning Labs Recalls L-Glutathione Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereDowning Labs Recalls HCG Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SevereDowning Labs Recalls Chromium Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SevereDowning Labs Recalls L-Arginine Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereRXQ Compounding Recalls Taurine Injectable Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SevereTri-Coast Pharmacy Recalls L-Tyrosine Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereWestern Drug Recalls Testosterone Injections Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- HighInjectable testosterone and dutasteride product recall for sterility assurance failure
FDA (Drugs) · 2021-11-17
- HighL-Carnitine Injectable Injection Recalled for Sterility Concerns
FDA (Drugs) · 2021-11-17
- SevereTestosterone Cypionate Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17